Comprehensive Pipeline Review on Ongoing Clinical and Pre-clinical studies
Hepatitis A (HAV) Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Hepatitis A (HAV) Infection pipeline products.
DISEASE OVERVIEW The disease is primarily transmitted from human-to-human through fecal-oral route and also through exposure to contaminated food. Primary symptoms include fever, fatigue, vomiting, stomach pain, dark colored urine and jaundice. Currently, two doses of hepatitis A vaccine are being administered to children to immune against Hepatitis-A infection.
Global Hepatitis A disease treatment market size is valued at $2 billion, primarily due to increasing prevalence and high treatment costs. An increasing trend in terms of incidences is driving a large number of pharmaceutical companies to invest their resources for Hepatitis A pipeline development.
Companies actively participating in Hepatitis-A pipeline product development include- Boryung Pharmaceuticals, Changchun Institute of Biological Products, Indian Immunologicals, PaxVax, Sinovac Biotech Ltd and Zydus Cadila.
REPORT DESCRIPTION The Hepatitis A (HAV) Infection pipeline guide presents complete overview of drugs currently being developed for Hepatitis A (HAV) Infection. The pipeline review provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials).
Drug development phase, current stage, mechanism of action, route of administration, orphan drug/ fast track/ other designations, drug class are provided for each of the Hepatitis A (HAV) Infection pipeline candidate.
Research and Development progress along with latest news related to each of the Hepatitis A (HAV) Infection pipeline candidates is included.
Major companies participating in therapeutic development of Hepatitis A (HAV) Infection are included in this pipeline report. Company wise pre-clinical and clinical products along with details of drug originator, co-developers/ licensors are provided.
Amid strong interest for cure of Hepatitis A (HAV) Infection from companies and institutes, the current research work serves as a reliable and comprehensive source of information of global Hepatitis A (HAV) Infection clinical and pre-clinical products.
The report assists in identifying potential upcoming companies and drugs in Hepatitis A (HAV) Infection pipeline market along with progress of each drug. It also enables users to formulate effective strategies to stay ahead of competition.
Information in the report is sourced from our proprietary platform, built through extensive primary and secondary research methodology. Data is presented in user friendly and ready to use format.
Scope of Hepatitis A (HAV) Infection pipeline report includes - Panorama of Hepatitis A (HAV) Infection pipeline markets including statistics on therapeutic drugs and companies involved
- Hepatitis A (HAV) Infection Pipeline candidates across various development phases including both pre-clinical, discovery and clinical stages are covered
- Hepatitis A (HAV) Infection pipeline candidates across various ‘Mechanism of Actions’ are also presented in the study
- Overview of companies participating in Hepatitis A (HAV) Infection pipeline with short introduction to their businesses and pipeline projects
- For each pipeline candidate, drug overview, details of mechanism of Action (MOA), originator, co-developer and licensee are provided.
- Research and Development progress and trial details, results wherever available, are also included in the pipeline study
- The pipeline study provides information on all ongoing and active projects and also presents the recent news associated with Hepatitis A (HAV) Infection pipeline therapeutics
Reasons to Buy - Get clear understanding of the entire Hepatitis A (HAV) Infection pipeline, with details on active projects
- Get in detail information of each product with updated information on each project along with key milestones
- Know the list of companies participating in global Hepatitis A (HAV) Infection pipeline along with progress of each of the company’s products and information on associations/collaborations/licensing data
- Get trial information for each pipeline product under development
- Understand the pipeline structure in terms of mechanism of Action, phase and company
Our reports have been used by over 10K customers, including:
646 pages •
By Global Industry Analysts
• May 2021
Global Laparoscopic Devices Market to Reach $15.8 Billion by 2026
Laparoscopy is a form of minimally invasive surgery used in studying organs in pelvic and abdominal area of the body. The introduction of laparoscopic techniques revolutionized the surgical world through a gradual...
Intravenous (IV) solutions are a complete mix of essential nutrients which are intended to replenish fluid losses, treat electrolyte imbalances and maintain fluid balance in intravenous therapy. They also provide required nutrients to the patients suffering from diabetes, cancer and other diseases. Intravenous solutions...
Melanoma - Epidemiology Forecast to 2029
Melanoma is a malignant neoplasm of melanocytes, the pigment cells in the skin located on the epidermis, the most superficial layer of the skin (World Health Organization, 2017).Melanocytes are embryological derivatives of neural crest tissue, and...
278 pages •
By Global Industry Analysts
• Apr 2021
- Global Anatomic Pathology Market to Reach $26.3 Billion by 2027
- Amid the COVID-19 crisis, the global market for Anatomic Pathology estimated at US$18.7 Billion in the year 2020, is projected to reach a revised size of US$26.3 Billion by 2027, growing at a CAGR of 4.9% over the analysis period 2020-2027....
185 pages •
By Global Industry Analysts
• Apr 2021
- Global Pathology Instruments Market to Reach $4.3 Billion by 2027
- Amid the COVID-19 crisis, the global market for Pathology Instruments estimated at US$3 Billion in the year 2020, is projected to reach a revised size of US$4.3 Billion by 2027, growing at a CAGR of 5.2% over the analysis period 2020-2027....
This report was created for global strategic planners who cannot be content with traditional methods of segmenting world markets. With the advent of a "borderless world", cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report covers the top 2,000 cities in over 200 countries....
Interleukin 1 (IL1) - Drugs in Development, 2021 Summary According to the recently published report ’Interleukin 1 - Drugs in Development, 2021’; Interleukin 1 (IL1) pipeline Target constitutes close to 36 molecules. Out of which approximately 35 molecules are developed by companies and remaining...
The Global Magnetic Beads Market size is expected to reach $2 billion by 2026, rising at a market growth of 12.7% CAGR during the forecast period. Magnetic beads refer to a tool, which is made up of small particles of iron oxides like magnetite that provide superparamagnetic properties to these beads. They do not attract one another when they...
120 pages •
By Infiniti Research Limited
• Mar 2021
Global Pathology Instruments Market 2021-2025 The analyst has been monitoring the pathology instruments market and it is poised to grow by $ 1.23 bn during 2021-2025 progressing at a CAGR of 6% during the forecast period. Our report on pathology instruments market provides a holistic analysis, market size and forecast,...
200 pages •
By The Business Research Company
• Mar 2021
Major players in the ultra-low temperature freezers market are Arctiko, Eppendorf, Esco Micro Pte Ltd, Haier, Helmer Scientific, Bionics Scientific Technologies (P). Ltd, PHC Holdings Corporation, Labcold Ltd, Remi Group, and Stirling Ultracold. The global ultra-low temperature freezers market is expected to decline from $633.94 million...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.